COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
AveXis is a clinical-stage gene therapy company developing an AAV9-delivered SMN gene therapy for infants with spinal muscular atrophy Type 1, currently in Phase I trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors